Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02109237

Sleep Disorders in Bronchiolitis Obliterans Syndrome 2&3

The Prevalence and Treatment of Sleep Disorders in Lung Transplant Recipients With BOS 2 & 3 and the Influence on Quality of Life and Daytime Activity.

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
The Prince Charles Hospital · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is to determine whether sleep disorders contribute to impaired quality of life and mobility in patients with Bronchiolitis Obliterans syndrome and whether non invasive positive airways pressure ventilation can improve sleep, quality of life and mobility in this patient group.

Detailed description

Patients with Bronchiolitis Obliterans syndrome (BOS) 2 \& 3 (25) will be matched 1:2 BOS 0 patients with similar demographics such as age, gender, BMI, time post transplant and renal dysfunction.Patients fitting inclusion/exclusion criteria once they have given informed consent will complete questionnaires on quality of life (QOL), any sleep issues they may have and be assessed by a doctor. Data from standard blood tests, respiratory function tests and physio assessments of daytime activity, mobility and muscle strength will be collected. All participants will undergo an overnight sleep study. If a sleep disorder is identified the participant will be offered appropriate treatment. All assessments with the exception of the sleep study will be repeated at 6 and 12 months post sleep study.

Conditions

Interventions

TypeNameDescription
PROCEDUREAssessment of sleep disorders and treatment if requiredAssessment of sleep disorders and treatment if required

Timeline

Start date
2014-05-01
Primary completion
2020-05-01
Completion
2020-05-01
First posted
2014-04-09
Last updated
2020-05-13

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT02109237. Inclusion in this directory is not an endorsement.

Sleep Disorders in Bronchiolitis Obliterans Syndrome 2&3 (NCT02109237) · Clinical Trials Directory